Get the Stockscreener App
5.35
5.56%
-0.315
Prenetics Global Limited stock is traded at $5.35, with a volume of 8,466.
It is down -5.56% in the last 24 hours and up +3.18% over the past month.
Prenetics Global Ltd is a health sciences company dedicated to consumer and clinical health. Its consumer initiative is led by IM8, a new health and wellness brand, and Europa, a U.S. sports distribution company. The clinical division is led by Insighta, focused on multi-cancer early detection technologies. This is followed by ACT Genomics, which has achieved FDA clearance for genomic profiling of solid tumors, and CircleDNA, which uses NGS to offer DNA tests. Each Prenetics unit impacts health by 'enhancing life through science'.
See More
Previous Close:
$5.665
Open:
$5.77
24h Volume:
8,466
Relative Volume:
0.66
Market Cap:
$65.36M
Revenue:
$291.44M
Net Income/Loss:
$-44.17M
P/E Ratio:
-1.2738
EPS:
-4.2
Net Cash Flow:
-
1W Performance:
-5.81%
1M Performance:
+3.18%
6M Performance:
-10.23%
1Y Performance:
+3.28%
1-Day Range:
$5.22
$5.77
1-Week Range:
$5.22
$5.90
52-Week Range:
$2.85
$7.838
Prenetics Global Limited Stock (PRE) Company Profile
Name
Prenetics Global Limited
Sector
Industry
Phone
-
Address
-
Compare PRE with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PRE
Prenetics Global Limited
|
5.35 | 65.36M | 291.44M | -44.17M | 0 | -4.20 |
|
TMO
Thermo Fisher Scientific Inc
|
544.93 | 208.44B | 42.37B | 6.14B | 7.78B | 15.95 |
|
DHR
Danaher Corp
|
238.09 | 171.97B | 23.74B | 3.89B | 4.98B | 5.24 |
|
A
Agilent Technologies Inc
|
137.00 | 39.13B | 6.51B | 1.29B | 1.37B | 4.42 |
|
IQV
Iqvia Holdings Inc
|
204.32 | 37.08B | 15.32B | 1.41B | 1.96B | 7.62 |
|
IDXX
Idexx Laboratories Inc
|
432.36 | 35.40B | 3.84B | 866.24M | 792.60M | 10.37 |
Prenetics Global Limited Stock (PRE) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-18-23 | Initiated | Cantor Fitzgerald | Overweight |
Prenetics Global Limited Stock (PRE) Latest News
Financial Comparison: Prenetics Global (NASDAQ:PRE) and 10x Genomics (NASDAQ:TXG) - Defense World
Where are the Opportunities in (PRE) - Stock Traders Daily
Short Interest in Prenetics Global Limited (NASDAQ:PRE) Rises By 23.6% - MarketBeat
Prenetics Global (NASDAQ:PRE) Shares Down 1.6% – Here’s Why - Defense World
Prenetics Global (NASDAQ:PRE) Trading Down 1.6%What's Next? - MarketBeat
Prenetics' IM8 Announces Collaboration with Mayo Clinic to Develop New Line of Premium Supplements - The Manila Times
Prenetics’ IM8 Announces Collaboration with Mayo Clinic to Develop New Line of Premium Supplements - GlobeNewswire
Prenetics Global Limited's (NASDAQ:PRE) P/S Is Still On The Mark Following 32% Share Price Bounce - Simply Wall St
Prenetics Global Announces 2024 Annual General Meeting - TipRanks
iAccess Alpha's Buyside Best Ideas Virtual Winter Conference December 10-11, 2024 - Financial Content
Prenetics' IM8 and University of Oxford Begin Groundbreaking Space Experiment to Study Accelerated Aging and Longevity on the ISS with SpaceX, Supported by Space Applications Services - The Manila Times
Prenetics’ IM8 and University of Oxford Begin Groundbreaking Space Experiment to Study Accelerated Aging and Longevity on the ISS with SpaceX, Supported by Space Applications Services - GlobeNewswire
Prenetics' IM8 Launches Pioneering Longevity Research on International Space Station with Oxford - StockTitan
Prenetics Announces Participation in December Investor Conferences - The Manila Times
Prenetics Global CEO to Present at iAccess Alpha Conference; Set for ROTH Deer Valley Event - StockTitan
Contrasting Prenetics Global (NASDAQ:PRE) and Standard BioTools (NASDAQ:LAB) - Defense World
Prenetics Global Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Prenetics Announces Third Quarter 2024 Financial Results - The Manila Times
Prenetics Reports Strong Growth with New Launches - TipRanks
Prenetics Announces Third Quarter 2024 Financial Results | DigitalMore.co - Digital More
Prenetics Global Q3 Revenue Surges 59% to $7.8M, Secures $30M Tencent Investment | PRE Stock News - StockTitan
Prenetics Announces the Launch of IM8 Health - Marketscreener.com
MULTIMEDIA UPDATE -- Nasdaq-Listed Prenetics and David Beckham Officially Launch IM8 Health - The Bakersfield Californian
Nasdaq-Listed Prenetics and David Beckham Officially Launch IM8 Health - The Manila Times
Prenetics Global And 2 Other US Penny Stocks To Watch - Yahoo Finance
Sidoti Events, LLC's Virtual November Micro-Cap Conference - WICZ
PREPrenetics Global Limited Latest Stock News & Market Updates - StockTitan
Ellington Financial Announces Full Redemption of Series E Preferred Stock for $24.4M | PRE Stock News - StockTitan
Prenetics Announces Participation in the Sidoti Virtual Micro Cap Investor Conference - The Manila Times
Genetic Genealogy Market Expected to Reach $1.69 Billion by 2031, Growing at 8.3% CAGR - WhaTech
Prenetics Acquires ACT Genomics; First M&A Deal since IPO, Set to Expand Footprint in Cancer Genomics - AsiaOne
Tencent invests $30M in Insighta to progress cancer diagnostics platform - BioWorld Online
Cantor Fitzgerald Initiates Coverage on Prenetics with "Overweight" Rating, Business Wires News - AsiaOne
Tencent invests $30m into HK-based early cancer detection firm - FinanceAsia
Prenetics (PRE) Stock Soars After Key Equity Announcement - Stocks Telegraph
Prenetics Announces Tencent's US$30 Million Investment in Insighta, Strengthening Strategic Partnership for - Digital More
Prenetics Announces Tencent's US$30 Million Investment in Insighta, Strengthening Strategic Partnership for AI-Driven Early Cancer Detection - The Manila Times
Prenetics announces Tencent's US$30 Million investment in Insighta - Vietnam Investment Review
Prenetics Announces Tencent’s US$30 Million Investment in Insighta, Strengthening Strategic - The Bakersfield Californian
Prenetics Announces Tencent’s US$30 Million Investment in Insighta, Strengthening Strategic Partnership for AI-Driven Early Cancer Detection - StockTitan
Prenetics Global Limited's (NASDAQ:PRE) Earnings Haven't Escaped The Attention Of Investors - Simply Wall St
Prenetics Global Second Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag - Simply Wall St
Prenetics Announces Second Quarter 2024 Financial Results - The Manila Times
Prenetics Global Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024 - Marketscreener.com
Citi Initiates Coverage on Prenetics Global with "Buy" Rating, Target Price at USD8.10, Business Wires News - AsiaOne
NEOG Stock Declines Amidst Market Volatility in Life Sciences Se - GuruFocus.com
Prenetics Gains Auditor Consent for Financials - TipRanks
Prenetics Global Limited (NASDAQ:PRE) Short Interest Update - Defense World
Prenetics Announces MOU for a Strategic Investment and 5-Year Research Collaboration with Metavisionaries to Pioneer R&D on the International Space Station - Thailand Business News
Prenetics Global Limited Stock (PRE) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.34%
0.43%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):